ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio Corporation announced today that it will present compelling new data highlighting preclinical milestones in the development of its novel topical treatments for acne and fungal infections. The new data will be delivered in three poster presentations during the 2009 annual meeting of the Society of Investigative Dermatology in Montreal, Canada, from May 6-9, 2009.
